Jorgen Hansen

Title: Jorgen Hansen: Innovator in Glycoside Production

Introduction

Jorgen Hansen, based in Frederiksberg, Denmark, is a notable inventor with a strong portfolio of 18 patents. His groundbreaking work focuses on the production of glycosides, which have important applications in food and beverage industries. With a career spanning several years, Hansen's contributions have significantly advanced the methods of glycoside production.

Latest Patents

Jorgen Hansen's latest innovations include patents for "Methods for Improved Production of Rebaudioside D and Rebaudioside M" and "Methods and Materials for Biosynthesis of Mogroside Compounds." The former patent details techniques for recombinant production of steviol glycosides and compositions that contain these compounds. Meanwhile, his second patent highlights methods for both recombinant and enzymatic production of mogroside compounds, further expanding the capabilities of glycoside production in various applications.

Career Highlights

Throughout his career, Hansen has made significant strides in the field of glycoside production. He has worked with reputable companies such as Evolva SA and Carlsberg A/S, where he applied his innovative approaches to enhance production techniques. His experience in these leading firms has equipped him with the knowledge and skills necessary to tackle complex challenges in glycoside synthesis.

Collaborations

In his journey as an inventor, Jorgen Hansen has collaborated with talented professionals, including Jens Houghton-Larsen and Ernesto Simon. These collaborations have fostered a rich exchange of ideas and techniques, leading to further advancements in his specialized field of research.

Conclusion

Jorgen Hansen stands out as an influential inventor in the realm of glycoside production. His impressive patent portfolio and collaborative efforts continue to drive innovation and improve methodologies, contributing positively to the industries he serves. With a passion for discovery, Hansen remains a key figure in the advancement of biotechnological applications related to glycosides.